Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Infect Drug Resist ; 11: 2169-2178, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30519054

RESUMO

INTRODUCTION: Cancer is alarmingly increased in developing countries like Ethiopia, where multidrug resistant bacterial infection is rampant. The aim of this study was to determine the bacterial profile, antimicrobial resistance pattern, and associated factors among cancer patients attending University of Gondar Hospital. METHODS: A consecutive 216 cancer patients were recruited from February to April, 2017. Socio-demographic and clinical data were collected using a structured questionnaire. Culture and antibiotic resistance were done following standard microbiological procedures. RESULT: The overall prevalence of bacterial infection was 19.4%. The predominant bacterial isolates were Staphylococcus aureus (28.6%), followed by coagulase negative staphylococci (26.2%) and Escherichia coli (21.4%). Multidrug resistance was detected in 46.5% bacterial isolates. Methicillin resistance was detected in 25% of S. aureus and in 45.5% of coagulase negative staphylococci. Fluoroquinolone resistance was detected in 33.3% of E. coli isolates. Cancer patients with solid tumor, started cancer therapy, and being symptomatic had higher odds of culture positivity. CONCLUSION: The overall burden of bacterial infection among cancer patients is considerably high. The findings of this study inform baseline information for policymakers and call for additional studies with large isolates in different cancer treatment centers in the region and in the country to better understand the bacterial isolate and resistance pattern.

2.
Clin Infect Dis ; 65(12): 2126-2129, 2017 Nov 29.
Artigo em Inglês | MEDLINE | ID: mdl-29020172

RESUMO

A total of 817 human immunodeficiency virus-infected Ethiopians with CD4 <150 cells/mL underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of participants with plasma CRAG titers >1:640, 96% (27 of 28) had cryptococcal meningitis (cerebrospinal fluid CRAG-positive) whereas 50% (7 of 14) with 1:160-1:320 titers had meningitis. With fluconazole 1200 mg/d therapy, 68% of meningitis patients (23 of 34) died within 3 months. Plasma CRAG titers >1:160 predict meningitis, requiring more intensive antifungal therapy.


Assuntos
Antifúngicos/efeitos adversos , Antígenos de Fungos/efeitos dos fármacos , Fluconazol/efeitos adversos , Infecções por HIV/complicações , Meningite Criptocócica/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/complicações , Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Infecções Oportunistas Relacionadas com a AIDS/virologia , Adulto , Antifúngicos/administração & dosagem , Antifúngicos/uso terapêutico , Antígenos de Fungos/líquido cefalorraquidiano , Cryptococcus/efeitos dos fármacos , Etiópia/epidemiologia , Feminino , Fluconazol/administração & dosagem , Fluconazol/uso terapêutico , Infecções por HIV/epidemiologia , Infecções por HIV/virologia , Soropositividade para HIV , Humanos , Masculino , Programas de Rastreamento , Meningite Criptocócica/sangue , Meningite Criptocócica/epidemiologia , Meningite Criptocócica/prevenção & controle , Mortalidade , Prevalência , Estudos Prospectivos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...